Trial Profile
Clinical Trials Insight: 700036521
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 22 Aug 2008
Price :
$35
*
At a glance
- Drugs KRP 104 (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Kyorin Pharmaceutical
- 22 Aug 2008 New trial record.
- 20 Aug 2008 Results reported by Kyorin in a company media release.